Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Development and measurement of guideline-based indicators for patients with non-Hodgkin's lymphomaLianne Wennekes, Petronella B Ottevanger, John M Raemaekers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2020
Changes in body weight and serum liver tests associated with parenteral nutrition compared with no parenteral nutrition in patients with acute myeloid leukemia during remission induction treatmentRianne van Lieshout, Lidwine W Tick, Jeanne P Dieleman, et al.
Haematologica|November 22, 2015
Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMTAngelique V M Brands-Nijenhuis, Myriam Labopin, Harry C Schouten, et al.
Breast Cancer Research and Treatment|January 29, 2011
Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of micePeter W H Frings, Catharina H M J Van Elssen, Lotte Wieten, et al.
Bone Marrow Transplantation|May 17, 2020
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMTAnna Sureda, Sonja Genadieva Stavrik, Ariane Boumendil, et al.
Thrombosis and Haemostasis|January 1, 2019
Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based ExperimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.
Clinical Nutrition ESPEN|September 22, 2023
Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectivesRianne van Lieshout, Lidwine W Tick, Fenne de Beer, et al.
Haematologica|October 13, 2005
Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalitiesHanneke M van der Straaten, Anja van Biezen, Ronald Brand, et al.
European Journal of Internal Medicine|March 17, 2020
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experimentAvi Leader, Vincent Ten Cate, Arina J Ten Cate-Hoek, et al.
Journal of Hematology & Oncology|March 17, 2018
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMTAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Pageof 14